Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Looking at skin can help find and treat serious diseases early.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Skin conditions can signal heart issues, highlighting the need for integrated care.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Inflammatory skin conditions are the most common in Brazilian children, with atopic dermatitis being the top issue.

The conclusion of the case is not provided in the summary.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The pandemic highlighted the need for accurate information, vaccine development, and adapting to new routines while managing stress and misinformation.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

COVID-19 may cause hair loss due to infection stress or treatments.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Consider benefits and risks of new alopecia treatments for safety.

Panniculitis in dermatomyositis is rare, more common in women, and may persist despite treatment.

Elderly patients frequently suffer from skin conditions, especially inflammatory ones, highlighting the need for better healthcare.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.